首页 > 最新文献

Hno最新文献

英文 中文
[Is AIT worth your while? Economic evaluation of allergen-specific immunotherapy (AIT) for otorhinolaryngologists in private practice].
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-03 DOI: 10.1007/s00106-024-01542-8
U Reineke, C Cappello

The burden of allergic diseases is significant for patients, payers in the healthcare system, and the political economy. Numerous studies have demonstrated the efficacy and cost-effectiveness of allergen immunotherapy (AIT) compared to symptomatic treatments. However, allergic patients in Germany often do not receive adequate treatment. This study aims to investigate the reimbursement of allergy diagnostics and AIT for ear, nose, and throat (ENT) physicians in private practice. A model calculation was conducted to assess the reimbursement of allergology services across 12 statutory health insurance associations (Kassenärztliche Vereinigungen, KV) based on the Physician Fee Schedule (Einheitlicher Bewertungsmaßstab, EBM) and KV-specific regulations for the year 2022 [20, 22]. Reimbursement was calculated according to EBM values and with a reduced point value. Quarterly reimbursement for a 3-year therapy and hourly rates for subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) were analyzed and compared with the average reimbursement per case (durchschnittlicher Honorarumsatz je Behandlungsfall, DHPB). Adherence to the budget resulted in ENT physicians being reimbursed above the DHPB for SCIT in every KV. This remained true for most KVs, even when the excess to the case value was only rewarded at 15%. Reimbursement for a 3-year SLIT was lower than the DHPB across all KVs. Allergy diagnostics and AIT represent economically advantageous options for ENT practices. Maintenance therapy demonstrates a positive cost-benefit ratio, supporting the call for a consistent 3‑year treatment regimen.

{"title":"[Is AIT worth your while? Economic evaluation of allergen-specific immunotherapy (AIT) for otorhinolaryngologists in private practice].","authors":"U Reineke, C Cappello","doi":"10.1007/s00106-024-01542-8","DOIUrl":"https://doi.org/10.1007/s00106-024-01542-8","url":null,"abstract":"<p><p>The burden of allergic diseases is significant for patients, payers in the healthcare system, and the political economy. Numerous studies have demonstrated the efficacy and cost-effectiveness of allergen immunotherapy (AIT) compared to symptomatic treatments. However, allergic patients in Germany often do not receive adequate treatment. This study aims to investigate the reimbursement of allergy diagnostics and AIT for ear, nose, and throat (ENT) physicians in private practice. A model calculation was conducted to assess the reimbursement of allergology services across 12 statutory health insurance associations (Kassenärztliche Vereinigungen, KV) based on the Physician Fee Schedule (Einheitlicher Bewertungsmaßstab, EBM) and KV-specific regulations for the year 2022 [20, 22]. Reimbursement was calculated according to EBM values and with a reduced point value. Quarterly reimbursement for a 3-year therapy and hourly rates for subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) were analyzed and compared with the average reimbursement per case (durchschnittlicher Honorarumsatz je Behandlungsfall, DHPB). Adherence to the budget resulted in ENT physicians being reimbursed above the DHPB for SCIT in every KV. This remained true for most KVs, even when the excess to the case value was only rewarded at 15%. Reimbursement for a 3-year SLIT was lower than the DHPB across all KVs. Allergy diagnostics and AIT represent economically advantageous options for ENT practices. Maintenance therapy demonstrates a positive cost-benefit ratio, supporting the call for a consistent 3‑year treatment regimen.</p>","PeriodicalId":55052,"journal":{"name":"Hno","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143124176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The use of fracture sonography in midface traumatology]. [骨折超声造影在中面部创伤学中的应用]。
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-01 Epub Date: 2024-12-16 DOI: 10.1007/s00106-024-01541-9
Maximilian Rink, Ole Ackermann, Christoph Sproll, Luisa Symeou, Lukas Pillong, Johannes Weimer, Julian Künzel

Ultrasound is today an essential element of otorhinolaryngology. During the course of (technical) development, fracture sonography has also gained increasing clinical and scientific interest. Sonography can already be used today as the imaging method of choice for isolated suspected fractures of the nasal or zygomatic bone. Sonography can also be helpful for immediate monitoring of repositioning. In the diagnosis of more complex fractures, however, cross-sectional imaging is still required. This article provides an overview of the possibilities and limitations of fracture sonography in the midface region and offers an introduction to the topic. The performance of the most important examinations is explained using images, and possible pitfalls are outlined.

超声是当今耳鼻喉科的重要组成部分。在(技术)发展的过程中,骨折超声也获得了越来越多的临床和科学兴趣。今天,超声已经可以作为鼻骨或颧骨分离疑似骨折的首选成像方法。超声检查也可以帮助立即监测重新定位。然而,在诊断更复杂的骨折时,仍然需要横断面成像。本文概述了裂缝超声在中面区域的可能性和局限性,并对该主题进行了介绍。使用图像解释了最重要的考试的性能,并概述了可能的陷阱。
{"title":"[The use of fracture sonography in midface traumatology].","authors":"Maximilian Rink, Ole Ackermann, Christoph Sproll, Luisa Symeou, Lukas Pillong, Johannes Weimer, Julian Künzel","doi":"10.1007/s00106-024-01541-9","DOIUrl":"10.1007/s00106-024-01541-9","url":null,"abstract":"<p><p>Ultrasound is today an essential element of otorhinolaryngology. During the course of (technical) development, fracture sonography has also gained increasing clinical and scientific interest. Sonography can already be used today as the imaging method of choice for isolated suspected fractures of the nasal or zygomatic bone. Sonography can also be helpful for immediate monitoring of repositioning. In the diagnosis of more complex fractures, however, cross-sectional imaging is still required. This article provides an overview of the possibilities and limitations of fracture sonography in the midface region and offers an introduction to the topic. The performance of the most important examinations is explained using images, and possible pitfalls are outlined.</p>","PeriodicalId":55052,"journal":{"name":"Hno","volume":" ","pages":"152-162"},"PeriodicalIF":0.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Acceptance of digital apps in the follow-up of patients with head and neck tumors]. [数字应用程序在头颈部肿瘤患者随访中的接受度]。
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-01 Epub Date: 2024-05-03 DOI: 10.1007/s00106-024-01463-6
Christopher Weusthof, Zhaojun Zhu, Anne Ruck, Amir Bolooki, Oliver Schöffski, Barbara Wollenberg, Markus Wirth

Background: Patient-reported outcome (PRO) measures lead to improved quality of life in cancer patients and possibly to earlier detection of tumor recurrence.

Objective: Patient interest in complementing tumor follow-up care with apps for recording PROs was assessed using a questionnaire.

Materials and methods: An independently created questionnaire to record the interest of tumor patients in a digitalized form of tumor follow-up care was evaluated (n = 110).

Results: In the study, the majority of tumor patients were interested in using an app for tumor disease. Taking age into account, the number increased even further for patients < 60 years of age, as expected. In line with this, human papillomavirus (HPV)-positive patients showed significantly greater interest (p = 0.021).

Conclusion: The introduction of an app is supported by the majority of tumor patients. In addition to recording PROs, other applications (appointment reminders, patient files, sports/nutrition programs) could also be integrated.

背景:患者报告结果(PRO)测量可提高癌症患者的生活质量,并有可能提早发现肿瘤复发:患者报告结果(PRO)测量可提高癌症患者的生活质量,并有可能更早地发现肿瘤复发:通过问卷调查评估了患者对使用记录PROs的应用程序补充肿瘤随访护理的兴趣:独立制作的调查问卷记录了肿瘤患者对数字化肿瘤随访护理的兴趣(n = 110):在研究中,大多数肿瘤患者对使用肿瘤疾病应用程序感兴趣。考虑到患者的年龄,这一数字进一步上升:大多数肿瘤患者都支持使用应用程序。除了记录 PROs 之外,还可以整合其他应用程序(预约提醒、患者档案、运动/营养程序)。
{"title":"[Acceptance of digital apps in the follow-up of patients with head and neck tumors].","authors":"Christopher Weusthof, Zhaojun Zhu, Anne Ruck, Amir Bolooki, Oliver Schöffski, Barbara Wollenberg, Markus Wirth","doi":"10.1007/s00106-024-01463-6","DOIUrl":"10.1007/s00106-024-01463-6","url":null,"abstract":"<p><strong>Background: </strong>Patient-reported outcome (PRO) measures lead to improved quality of life in cancer patients and possibly to earlier detection of tumor recurrence.</p><p><strong>Objective: </strong>Patient interest in complementing tumor follow-up care with apps for recording PROs was assessed using a questionnaire.</p><p><strong>Materials and methods: </strong>An independently created questionnaire to record the interest of tumor patients in a digitalized form of tumor follow-up care was evaluated (n = 110).</p><p><strong>Results: </strong>In the study, the majority of tumor patients were interested in using an app for tumor disease. Taking age into account, the number increased even further for patients < 60 years of age, as expected. In line with this, human papillomavirus (HPV)-positive patients showed significantly greater interest (p = 0.021).</p><p><strong>Conclusion: </strong>The introduction of an app is supported by the majority of tumor patients. In addition to recording PROs, other applications (appointment reminders, patient files, sports/nutrition programs) could also be integrated.</p>","PeriodicalId":55052,"journal":{"name":"Hno","volume":" ","pages":"122-128"},"PeriodicalIF":0.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11772454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140869130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chronic rhinosinusitis was neither a risk nor a protective factor during the COVID-19 pandemic]. [在COVID-19大流行期间,慢性鼻窦炎既不是风险因素,也不是保护因素]。
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-01 Epub Date: 2024-11-29 DOI: 10.1007/s00106-024-01534-8
Hilmar Gudziol, Thomas Hummel, Orlando Guntinas-Lichius

Background: There are various views in the literature regarding the influence of chronic rhinosinusitis (CRS) as a comorbidity on the occurrence of COVID-19 disease.

Objective: Did CRS prevent or promote infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the coronavirus pandemic?

Materials and methods: We conducted a retrospective case-control study with 252 adult CRS patients who underwent sinus surgery between 2020 and 2023 and a non-CRS control group; both groups were comparable in terms of age and gender. The association between a history of COVID‑19 and CRS according to its phenotype and endotype was examined using cross tables and chi-square tests. We also analyzed self-reported and measured olfactory ability. Additionally, patients were asked about continuous preoperative use of inhaled corticosteroids.

Results: There was no association between CRS and COVID‑19. This applied both to CRS patients with or without nasal polyps (CRSwNP or CRSsNP) and to endotyping according to tissue eosinophilia. The majority of operated CRS patients were CRSwNP patients, predominantly male and younger compared to CRSsNP patients. CRSwNP presented eosinophilia 2.8 times more frequently than CRSsNP. CRSsNP patients had better reported and measured olfactory ability compared to CRSwNP patients. The measured olfactory ability of the CRS patients with COVID‑19 did not differ from that of CRS patients without C‑19. Preoperative use of inhaled corticosteroids was more frequent among CRSwNP patients than CRSsNP patients.

Conclusion: Chronic rhinosinusitis was neither a risk nor a protective factor for COVID‑19.

背景:关于慢性鼻窦炎(CRS)作为一种合并症对COVID-19疾病发生的影响,文献中有不同的观点。目的:在冠状病毒大流行期间,CRS是否预防或促进了SARS-CoV-2的感染?材料和方法:我们对2020年至2023年间接受鼻窦手术的252例成人CRS患者和非CRS对照组进行了回顾性病例对照研究;两组在年龄和性别方面具有可比性。采用交叉表和卡方检验检验COVID - 19病史与CRS表型和内型之间的关系。我们还分析了自我报告和测量的嗅觉能力。此外,患者被问及术前是否持续使用吸入性皮质类固醇。结果:CRS与COVID‑19无相关性。这既适用于伴有或不伴有鼻息肉的CRS患者(CRSwNP或CRSsNP),也适用于根据组织嗜酸性粒细胞增多进行内分型。与CRSsNP患者相比,大多数CRS手术患者为CRSwNP患者,以男性为主,年龄较小。CRSwNP出现嗜酸性粒细胞增多的频率是crsssnp的2.8倍。与CRSwNP患者相比,CRSsNP患者报告和测量的嗅觉能力更好。感染COVID - 19的CRS患者的嗅觉能力与未感染C - 19的CRS患者的嗅觉能力没有差异。CRSwNP患者术前吸入糖皮质激素的使用频率高于CRSsNP患者。结论:慢性鼻窦炎既不是COVID - 19的危险因素,也不是保护因素。
{"title":"[Chronic rhinosinusitis was neither a risk nor a protective factor during the COVID-19 pandemic].","authors":"Hilmar Gudziol, Thomas Hummel, Orlando Guntinas-Lichius","doi":"10.1007/s00106-024-01534-8","DOIUrl":"10.1007/s00106-024-01534-8","url":null,"abstract":"<p><strong>Background: </strong>There are various views in the literature regarding the influence of chronic rhinosinusitis (CRS) as a comorbidity on the occurrence of COVID-19 disease.</p><p><strong>Objective: </strong>Did CRS prevent or promote infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the coronavirus pandemic?</p><p><strong>Materials and methods: </strong>We conducted a retrospective case-control study with 252 adult CRS patients who underwent sinus surgery between 2020 and 2023 and a non-CRS control group; both groups were comparable in terms of age and gender. The association between a history of COVID‑19 and CRS according to its phenotype and endotype was examined using cross tables and chi-square tests. We also analyzed self-reported and measured olfactory ability. Additionally, patients were asked about continuous preoperative use of inhaled corticosteroids.</p><p><strong>Results: </strong>There was no association between CRS and COVID‑19. This applied both to CRS patients with or without nasal polyps (CRSwNP or CRSsNP) and to endotyping according to tissue eosinophilia. The majority of operated CRS patients were CRSwNP patients, predominantly male and younger compared to CRSsNP patients. CRSwNP presented eosinophilia 2.8 times more frequently than CRSsNP. CRSsNP patients had better reported and measured olfactory ability compared to CRSwNP patients. The measured olfactory ability of the CRS patients with COVID‑19 did not differ from that of CRS patients without C‑19. Preoperative use of inhaled corticosteroids was more frequent among CRSwNP patients than CRSsNP patients.</p><p><strong>Conclusion: </strong>Chronic rhinosinusitis was neither a risk nor a protective factor for COVID‑19.</p>","PeriodicalId":55052,"journal":{"name":"Hno","volume":" ","pages":"129-135"},"PeriodicalIF":0.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Enhanced quality of documentation for biologic therapy of chronic rhinosinusitis through structured digital reporting and indication?] [通过结构化数字报告和适应症提高慢性鼻炎生物疗法的文件质量?]
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-01 Epub Date: 2024-05-30 DOI: 10.1007/s00106-024-01488-x
Jan Hagemann, Christopher Seifen, Laura Koll, Manuel Reissig, Barbara Leggewie, Berit Hackenberg, Julia Döge, Kai Helling, Sven Becker, Ludger Klimek, Christoph Matthias, Benjamin-Philipp Ernst

Background: With targeted inhibition of type 2 inflammation, biologics represent the standard add-on therapy for inadequately controlled severe forms of chronic rhinosinusitis with nasal polyps (CRSwNP). Despite standardization with paper-based checklists, the documentation of medical history and current findings pertinent to indication criteria are a significant challenge for physicians. Through development of an application based on structured reporting, the current study aimed to improve documentation quality and simplify the decision-making process. Previously available paper checklists served as a comparison.

Methods: For this study, a digital incremental tool was programmed to record current findings and check for fulfilment of indication criteria. The tool was compared with other checklists in terms of completeness, time required, and readability.

Results: A total of 20 findings were collected for each of the three documentation options and included in the analysis. Documentation with the two paper-based checklists had comparable information content: 17.5 ± 5.1/21.7 ± 7.6 points out of a maximum of 43 points; p > 0.05. Documentation using the digital application led to a significant increase in information content compared to all paper-based documentation. The average score was 38.25 ± 3.7 (88.9% of maximum; p < 0.001). On average, user satisfaction was high (9.6/10). Use of the digital application was initially more time consuming, but as more cases were documented, the time taken improved significantly.

Conclusion: In the future, structured reporting using apps could replace paper-based reporting for the indication of biologic therapy in CRSwNP patients and offer additional benefits in terms of data quality and traceability of results. The increasing volume of documentation in the future, the progress of digitalization, and the possibility of networking between individual centers make introduction of the app in the near future both likely and economical.

背景:生物制剂能靶向抑制 2 型炎症,是治疗未得到充分控制的严重慢性鼻炎伴鼻息肉(CRSwNP)的标准附加疗法。尽管使用纸质核对表实现了标准化,但与适应症标准相关的病史和当前检查结果的记录对医生来说仍是一项重大挑战。通过开发基于结构化报告的应用程序,本研究旨在提高记录质量并简化决策过程。方法:在这项研究中,我们开发了一种数字增量工具,用于记录当前的检查结果并检查是否符合适应症标准。该工具在完整性、所需时间和可读性方面与其他核对表进行了比较:结果:在三种记录方案中,每种方案共收集到 20 项检查结果并纳入分析。两种纸质核对表的记录信息内容相当:17.5 ± 5.1/21.7 ± 7.6 分(满分 43 分);P > 0.05。与所有纸质文件相比,使用数字应用程序编写文件的信息含量显著增加。平均得分为 38.25 ± 3.7 分(占最高分的 88.9%;P 结论:使用数字应用软件进行结构化报告是未来的趋势:未来,在 CRSwNP 患者的生物疗法适应症方面,使用应用程序进行结构化报告可取代纸质报告,并在数据质量和结果可追溯性方面带来更多益处。随着未来文件量的增加、数字化进程的推进以及各中心之间联网的可能性,在不久的将来引入应用程序既有可能又经济实惠。
{"title":"[Enhanced quality of documentation for biologic therapy of chronic rhinosinusitis through structured digital reporting and indication?]","authors":"Jan Hagemann, Christopher Seifen, Laura Koll, Manuel Reissig, Barbara Leggewie, Berit Hackenberg, Julia Döge, Kai Helling, Sven Becker, Ludger Klimek, Christoph Matthias, Benjamin-Philipp Ernst","doi":"10.1007/s00106-024-01488-x","DOIUrl":"10.1007/s00106-024-01488-x","url":null,"abstract":"<p><strong>Background: </strong>With targeted inhibition of type 2 inflammation, biologics represent the standard add-on therapy for inadequately controlled severe forms of chronic rhinosinusitis with nasal polyps (CRSwNP). Despite standardization with paper-based checklists, the documentation of medical history and current findings pertinent to indication criteria are a significant challenge for physicians. Through development of an application based on structured reporting, the current study aimed to improve documentation quality and simplify the decision-making process. Previously available paper checklists served as a comparison.</p><p><strong>Methods: </strong>For this study, a digital incremental tool was programmed to record current findings and check for fulfilment of indication criteria. The tool was compared with other checklists in terms of completeness, time required, and readability.</p><p><strong>Results: </strong>A total of 20 findings were collected for each of the three documentation options and included in the analysis. Documentation with the two paper-based checklists had comparable information content: 17.5 ± 5.1/21.7 ± 7.6 points out of a maximum of 43 points; p > 0.05. Documentation using the digital application led to a significant increase in information content compared to all paper-based documentation. The average score was 38.25 ± 3.7 (88.9% of maximum; p < 0.001). On average, user satisfaction was high (9.6/10). Use of the digital application was initially more time consuming, but as more cases were documented, the time taken improved significantly.</p><p><strong>Conclusion: </strong>In the future, structured reporting using apps could replace paper-based reporting for the indication of biologic therapy in CRSwNP patients and offer additional benefits in terms of data quality and traceability of results. The increasing volume of documentation in the future, the progress of digitalization, and the possibility of networking between individual centers make introduction of the app in the near future both likely and economical.</p>","PeriodicalId":55052,"journal":{"name":"Hno","volume":" ","pages":"103-110"},"PeriodicalIF":0.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11772524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pre-implementation of electronic patient-reported outcomes at reference centers for head and neck oncology : A roadmap towards patient-centered digitalization]. [在头颈部肿瘤参考中心预实施电子患者报告结果:以患者为中心的数字化路线图]。
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-01 Epub Date: 2025-01-16 DOI: 10.1007/s00106-024-01543-7
Daniel Dejaco, Timo Gottfried, Matthias Santer, Anna Thurner, Jens Lehmann, David Riedl, Gerhard Rumpold, Bernhard Holzner, Joachim Schmutzhard, Benedikt Hofauer

Background: Electronically captured patient reports (electronic patient-reported outcomes, ePROs) are digital questionnaires filled out by cancer patients. Despite indications of improved clinical care, the integration of ePROs into clinical head and neck oncology is uncharted territory.

Objective: This work outlines the implementation process for ePROs at the University Hospital for Otorhinolaryngology at the Medical University of Innsbruck (ENT Innsbruck).

Methods: The implementation is carried out by a project team in a pre-implementation phase (needs assessment, implementation planning, identification of intra-hospital barriers, prototype development, testing and adaptation, and user training), an implementation phase (implementation and user training), and a post-implementation phase (quality control and project expansion).

Results: The project team at ENT Innsbruck, consisting of 10 members, identified the need for digitalization in cancer follow-up. A hybrid implementation solution (Computer-Based Health Evaluation System, CHES; Evaluation Software Development, ESD, Innsbruck, Austria) was chosen. ePROs (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - 30 items, EORTC-QLQ-C30; Head and Neck Functional Integrity Scale, HNC-FIT scale; and EORTC Head and Neck Cancer Module, EORTC H&N43) will be collected 12 times over 5.5 years. A total of 25 users rated the prototype as user friendly (patient perspective: 8.1 ± 1.6, 3-10; user perspective: 8.6 ± 1.1, 6-10). The main advantage was faster medical history taking (72%), and the main disadvantages were a lack of personnel, time, and motivation (52%).

Conclusion: The feedback on the ePRO prototype at ENT Innsbruck was positive. The implementation phase commenced in the first quarter of 2024. Goal achievement will be evaluated in the post-implementation phase in the fourth quarter of 2024.

背景:电子捕获的患者报告(电子患者报告结果,ePROs)是由癌症患者填写的数字问卷。尽管有改善临床护理的迹象,但将ePROs整合到临床头颈部肿瘤中是一个未知的领域。目的:本工作概述了在因斯布鲁克医科大学耳鼻喉科大学医院实施ePROs的过程。方法:由项目团队在实施前阶段(需求评估、实施规划、识别院内障碍、原型开发、测试和适应、用户培训)、实施阶段(实施和用户培训)和实施后阶段(质量控制和项目扩展)进行实施。结果:因斯布鲁克耳鼻喉科的项目团队由10名成员组成,确定了数字化在癌症随访中的必要性。一种混合实施方案(基于计算机的健康评估系统,CHES;评估软件开发,ESD,因斯布鲁克,奥地利)被选中。欧洲癌症研究与治疗组织生活质量调查问卷- 30项,EORTC-QLQ-C30;头颈部功能完整性量表(HNC-FIT);和EORTC头颈癌模块(EORTC H&N43)将在5.5年内收集12次。共有25名用户对原型进行了用户友好性评价(患者角度:8.1 ±1.6,3-10;用户视角:8.6 ±1.1,6-10)。主要优点是更快地记录病史(72%),主要缺点是缺乏人员、时间和动机(52%)。结论:在因斯布鲁克耳鼻喉科,对ePRO原型的反馈是积极的。实施阶段于2024年第一季度开始。目标实现情况将在2024年第四季度的实施后阶段进行评估。
{"title":"[Pre-implementation of electronic patient-reported outcomes at reference centers for head and neck oncology : A roadmap towards patient-centered digitalization].","authors":"Daniel Dejaco, Timo Gottfried, Matthias Santer, Anna Thurner, Jens Lehmann, David Riedl, Gerhard Rumpold, Bernhard Holzner, Joachim Schmutzhard, Benedikt Hofauer","doi":"10.1007/s00106-024-01543-7","DOIUrl":"10.1007/s00106-024-01543-7","url":null,"abstract":"<p><strong>Background: </strong>Electronically captured patient reports (electronic patient-reported outcomes, ePROs) are digital questionnaires filled out by cancer patients. Despite indications of improved clinical care, the integration of ePROs into clinical head and neck oncology is uncharted territory.</p><p><strong>Objective: </strong>This work outlines the implementation process for ePROs at the University Hospital for Otorhinolaryngology at the Medical University of Innsbruck (ENT Innsbruck).</p><p><strong>Methods: </strong>The implementation is carried out by a project team in a pre-implementation phase (needs assessment, implementation planning, identification of intra-hospital barriers, prototype development, testing and adaptation, and user training), an implementation phase (implementation and user training), and a post-implementation phase (quality control and project expansion).</p><p><strong>Results: </strong>The project team at ENT Innsbruck, consisting of 10 members, identified the need for digitalization in cancer follow-up. A hybrid implementation solution (Computer-Based Health Evaluation System, CHES; Evaluation Software Development, ESD, Innsbruck, Austria) was chosen. ePROs (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - 30 items, EORTC-QLQ-C30; Head and Neck Functional Integrity Scale, HNC-FIT scale; and EORTC Head and Neck Cancer Module, EORTC H&N43) will be collected 12 times over 5.5 years. A total of 25 users rated the prototype as user friendly (patient perspective: 8.1 ± 1.6, 3-10; user perspective: 8.6 ± 1.1, 6-10). The main advantage was faster medical history taking (72%), and the main disadvantages were a lack of personnel, time, and motivation (52%).</p><p><strong>Conclusion: </strong>The feedback on the ePRO prototype at ENT Innsbruck was positive. The implementation phase commenced in the first quarter of 2024. Goal achievement will be evaluated in the post-implementation phase in the fourth quarter of 2024.</p>","PeriodicalId":55052,"journal":{"name":"Hno","volume":" ","pages":"95-102"},"PeriodicalIF":0.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11772396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Superior semicircular canal dehiscence isolation by transmastoid two-point canal plugging with preservation of the vestibulo-ocular reflex. German version]. [通过经乳突两点堵塞法隔离上半规管裂孔,保留前庭眼反射。德文版]。
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-01 Epub Date: 2024-11-28 DOI: 10.1007/s00106-024-01532-w
Ingmar Seiwerth, Julia Dlugaiczyk, Frank Schmäl, Torsten Rahne, Sabrina Kösling, Stefan K Plontke

This article describes the surgical treatment of superior semicircular canal dehiscence syndrome (SCDS) by isolating the dehiscence using transmastoid two-point canal plugging while preserving the high-frequency vestibulo-ocular reflex (VOR) of the affected semicircular canal. The superior semicircular canal is opened via a transmastoid approach anterior (as far from the ampulla as possible) and posterior to the dehiscence and then plugged with connective tissue and bone dust. In two clinical exemplary cases, vestibular testing showed that the VOR measured by video head impulse (vHIT) test was preserved (patient 1: gain preoperative 0.7, long-term postoperative 0.75; patient 2: gain preoperative 0.64, long-term postoperative 0.79; reduction of corrective saccades in each case) with a simultaneous reduction in pathologically increased amplitudes of vestibular evoked myogenic potentials (VEMPs) and a significant improvement in clinical symptoms with almost complete freedom from symptoms. One possible explanation for preservation of the high-frequency VOR of the superior semicircular canal would be the deformability of the endolymphatic space described at high stimulation frequencies, which can lead to endolymph movements in the area of the ampulla with deflection of the cupula despite blockage of the semicircular canal.

本文介绍了上半规管开裂综合征(SCDS)的手术治疗方法,即在保留受影响半规管的高频前庭眼反射(VOR)的同时,使用经乳突两点管塞法隔离开裂处。通过经乳突入路在裂孔的前方(尽可能远离咽鼓管)和后方打开上半规管,然后用结缔组织和骨粉进行堵塞。在两个临床典范病例中,前庭测试显示,通过视频头脉冲(vHIT)测试测量的 VOR 得到了保留(患者 1:术前增益为 0.7,术后长期增益为 0.75;患者 2:术前增益为 0.64,术后长期增益为 0.79;每个病例的矫正性囊视均有所减少),与此同时,前庭诱发肌源性电位(VEMPs)的病理性增高幅度也有所减小,临床症状明显改善,几乎完全摆脱了症状。保留上半规管高频 VOR 的一个可能的解释是,尽管半规管堵塞,但高频刺激下的内淋巴空间具有可变形性,这可能导致安瓿区域的内淋巴运动和杯状体偏转。
{"title":"[Superior semicircular canal dehiscence isolation by transmastoid two-point canal plugging with preservation of the vestibulo-ocular reflex. German version].","authors":"Ingmar Seiwerth, Julia Dlugaiczyk, Frank Schmäl, Torsten Rahne, Sabrina Kösling, Stefan K Plontke","doi":"10.1007/s00106-024-01532-w","DOIUrl":"10.1007/s00106-024-01532-w","url":null,"abstract":"<p><p>This article describes the surgical treatment of superior semicircular canal dehiscence syndrome (SCDS) by isolating the dehiscence using transmastoid two-point canal plugging while preserving the high-frequency vestibulo-ocular reflex (VOR) of the affected semicircular canal. The superior semicircular canal is opened via a transmastoid approach anterior (as far from the ampulla as possible) and posterior to the dehiscence and then plugged with connective tissue and bone dust. In two clinical exemplary cases, vestibular testing showed that the VOR measured by video head impulse (vHIT) test was preserved (patient 1: gain preoperative 0.7, long-term postoperative 0.75; patient 2: gain preoperative 0.64, long-term postoperative 0.79; reduction of corrective saccades in each case) with a simultaneous reduction in pathologically increased amplitudes of vestibular evoked myogenic potentials (VEMPs) and a significant improvement in clinical symptoms with almost complete freedom from symptoms. One possible explanation for preservation of the high-frequency VOR of the superior semicircular canal would be the deformability of the endolymphatic space described at high stimulation frequencies, which can lead to endolymph movements in the area of the ampulla with deflection of the cupula despite blockage of the semicircular canal.</p>","PeriodicalId":55052,"journal":{"name":"Hno","volume":" ","pages":"136-142"},"PeriodicalIF":0.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142741496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Unilateral obstruction of the nasal sinuses with epistaxis]. [单侧鼻窦阻塞伴鼻衄]。
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-01 Epub Date: 2024-10-23 DOI: 10.1007/s00106-024-01516-w
Berill Zsuzsanna Botos, Serkan Sertel, Simon-Michael Alperowitz, Christoph Käcker
{"title":"[Unilateral obstruction of the nasal sinuses with epistaxis].","authors":"Berill Zsuzsanna Botos, Serkan Sertel, Simon-Michael Alperowitz, Christoph Käcker","doi":"10.1007/s00106-024-01516-w","DOIUrl":"10.1007/s00106-024-01516-w","url":null,"abstract":"","PeriodicalId":55052,"journal":{"name":"Hno","volume":" ","pages":"143-145"},"PeriodicalIF":0.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Medical examination: preparation for ENT specialisation : Part 75]. [体格检查:耳鼻喉专科的准备:第75部分]。
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-01 Epub Date: 2025-01-13 DOI: 10.1007/s00106-024-01547-3
I Gutekunst, J Zenk
{"title":"[Medical examination: preparation for ENT specialisation : Part 75].","authors":"I Gutekunst, J Zenk","doi":"10.1007/s00106-024-01547-3","DOIUrl":"10.1007/s00106-024-01547-3","url":null,"abstract":"","PeriodicalId":55052,"journal":{"name":"Hno","volume":" ","pages":"146-151"},"PeriodicalIF":0.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Digitalization in otorhinolaryngology: data as the key to improved healthcare].
IF 0.8 4区 医学 Q4 OTORHINOLARYNGOLOGY
Hno
Pub Date : 2025-02-01 Epub Date: 2025-01-27 DOI: 10.1007/s00106-024-01545-5
Matthias P Schönermark, Benedikt Hofauer
{"title":"[Digitalization in otorhinolaryngology: data as the key to improved healthcare].","authors":"Matthias P Schönermark, Benedikt Hofauer","doi":"10.1007/s00106-024-01545-5","DOIUrl":"https://doi.org/10.1007/s00106-024-01545-5","url":null,"abstract":"","PeriodicalId":55052,"journal":{"name":"Hno","volume":"73 2","pages":"81-82"},"PeriodicalIF":0.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hno
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1